Trials / Unknown
UnknownNCT02426905
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
Multicentre, Retrospective and Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Univar BV · Industry
- Sex
- All
- Age
- 1 Year – 90 Years
- Healthy volunteers
- Not accepted
Summary
A study to review Wilson disease patients who have previously been prescribed d- Penicillamine but were changed to trientine as treatment for their disease, and to follow them for a further 12 months.
Detailed description
A retrospective study to review Wilson disease patients who have previously been prescribed d- Penicillamine but were changed to trientine as treatment for their disease, and to follow them prospectively for a further 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | trientine dihydrochloride | A retrospective review of patients' medical records |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-05-01
- Completion
- 2018-07-01
- First posted
- 2015-04-27
- Last updated
- 2017-08-23
Locations
4 sites across 4 countries: Germany, Greece, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT02426905. Inclusion in this directory is not an endorsement.